Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.4990
-0.0108 (-2.12%)
At close: Sep 1, 2026, 4:00 PM EDT
0.5100
+0.0110 (2.20%)
Pre-market: Sep 2, 2026, 6:04 AM EDT
Oragenics Market Cap
Oragenics has a market cap or net worth of $2.25 million as of September 2, 2026. Its market cap has decreased by -47.64% in one year.
Market Cap
2.25M
Enterprise Value
-1.61M
1-Year Change
-47.64%
Ranking
Category
Stock Price
$0.50
ChartMarket Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $1.60M to $2.25M, an increase of 40.72%. That is a compound annual growth rate of 1.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.30M | -30.30% |
| Dec 31, 2025 | 3.30M | -26.67% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.50% |
| Dec 31, 2009 | 27.20M | 186.32% |
| Dec 31, 2008 | 9.50M | -17.39% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.25% |
| Dec 31, 2004 | 55.30M | 3,356.25% |
| Feb 27, 2004 | 1.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genprex | 2.93M |
| Matinas BioPharma Holdings | 2.90M |
| Valion Bio | 2.72M |
| Clearmind Medicine | 2.72M |
| Jupiter Neurosciences | 2.58M |
| Onconetix | 2.58M |
| Propanc Biopharma | 2.57M |
| Virax Biolabs Group | 2.07M |